Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5506 to 5520 of 8224 results

  1. What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2 variants?

    Recommendation ID NG191/15 Question What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2

    Research recommendation
    Published
    9 March 2022

  2. What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological venous thromboembolism (VTE) prophylaxis for people with COVID-19, with or without additional risk factors for VTE?

    Recommendation ID NG191/1 Question What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological

    Research recommendation
    Published
    10 August 2021

  3. Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability of advocacy as a means of supporting people to make decisions?

    Recommendation ID NG108/3 Question Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability

    Research recommendation
    Published
    18 December 2018

  4. Dementia education and training programmes for family members and carers:- What is the effectiveness, cost effectiveness and acceptability of training programmes (forexample, in the use of life story work) for families of people growing older with learning disabilities who have dementia or are at risk of developing it?

    Recommendation ID NG96/4 Question Dementia education and training programmes for family members and carers:- What is the effectiveness

    Research recommendation
    Published
    29 November 2018

  5. Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention to treat people on haemodialysis with ESA‑resistant anaemia?

    Recommendation ID NG203/23 Question Treatment of ESA resistance in people on haemodialysis: What is the most effective type of intervention

    Research recommendation
    Published
    30 September 2021

  6. How to provide pelvic floor muscle training: What is the most effective way to provide pelvic floor muscle training (covering the type of training, the timing, and who should supervise it), to improve adherence and prevent pelvic floor dysfunction?

    Recommendation ID NG210/01 Question How to provide pelvic floor muscle training: What is the most effective way to provide pelvic floor

    Research recommendation
    Published
    7 January 2022

  7. In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal urinary antigen testing in addition to other routine tests improve outcomes?

    Recommendation ID CG191/1 Question In moderate- to high-severity community-acquired pneumonia does using legionella and pneumococcal urinary

    Research recommendation
    Published
    9 June 2015

  8. What is the clinical and cost effectiveness of inpatient rehabilitation provided by the independent sector compared with that provided by the NHS?

    Recommendation ID NG181/5 Question What is the clinical and cost effectiveness of inpatient rehabilitation provided by the independent

    Research recommendation
    Published
    26 October 2020

  9. In patients hospitalised with moderate- to high-severity community-acquired pneumonia, does using C-reactive protein monitoring in addition to clinical observation to guide antibiotic duration safely reduce the total duration of antibiotic therapy compared with a fixed empirical antibiotic course?

    Recommendation ID CG191/2 Question In patients hospitalised with moderate- to high-severity community-acquired pneumonia, does using C-reactive

    Research recommendation
    Published
    9 June 2015

  10. In patients with muscle-invasive bladder cancer suitable for radical treatment, does the use of biomarkers enable patients to select more effective treatment, and improve their outcomes, compared with treatment selected without biomarkers?

    Recommendation ID NG2/4 Question In patients with muscle-invasive bladder cancer suitable for radical treatment, does the use of biomarkers

    Research recommendation
    Published
    9 June 2015

  11. The effect of drug therapy for concurrent conditions on melanoma survival: In people diagnosed with melanoma what is the effect of drug therapy to treat concurrent conditions on disease specific survival? This should be investigated in a national prospective cohort study. Secondary outcomes should include overall survival and quality of life.

    Recommendation ID NG14/10 Question The effect of drug therapy for concurrent conditions on melanoma survival: In people diagnosed with

    Research recommendation
    Published
    4 August 2022

  12. Pharmacological prevention: In people in hospital who are at high risk of delirium, which medication (atypical antipsychotics, typical antipsychotics, benzodiazepines or acetylcholinesterase inhibitors), compared with placebo or each other, is more clinically and cost effective in preventing the development of delirium?

    Recommendation ID CG103/02 Question Pharmacological prevention: In people in hospital who are at high risk of delirium, which medication

    Research recommendation
    Published
    3 February 2023

  13. Pharmacological treatment: In people in hospital who have delirium, which is the most effective medication (atypical antipsychotics, typical antipsychotics or benzodiazepines) compared with placebo or each other for treating delirium?

    Recommendation ID CG103/03 Question Pharmacological treatment: In people in hospital who have delirium, which is the most effective medication

    Research recommendation
    Published
    3 February 2023

  14. How can the effectiveness of workplace health policies and programmes be measured?

    Recommendation ID NG13/3 Question How can the effectiveness of workplace health policies and programmes be measured? Any explanatory

    Research recommendation
    Published
    5 October 2015

  15. How can the factors that pose a risk to, or protect, the social and emotional wellbeing of children aged under 5 years be identified and assessed to determine how children can benefit from different interventions?

    Recommendation ID PH40/2 Question How can the factors that pose a risk to, or protect, the social and emotional wellbeing of children aged

    Research recommendation
    Published
    9 June 2015